Rebecca Wachter, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2365 Boston Post Rd Ste 203, Larchmont, NY 10538 Phone: 914-235-3800 |
Dr. Holly Caren Schachner, M.D. Pediatrics - Pediatric Endocrinology Medicare: Not Enrolled in Medicare Practice Location: 7 Winslow Pl, Larchmont, NY 10538 Phone: 914-833-9596 |
Dr. Cindi Louise Hartz, Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 1415 Boston Post Rd, Larchmont, NY 10538 Phone: 914-833-1502 Fax: 914-833-3607 |
Dr. Alain A. Le Guillou, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2039 Palmer Ave, Suite 203, Larchmont, NY 10538 Phone: 914-834-1590 Fax: 914-315-6225 |
News Archive
Research led by Dr. Udai Pandey, Assistant Professor of Genetics at LSU Health Sciences Center New Orleans, has found that the ability of a protein made by a gene called FUS to bind to RNA is essential to the development of Amyotrophic Lateral Sclerosis (ALS). This discovery identifies a possible therapeutic target for the fatal neurological disease.
In the largest prospective study to date of children with early and later manifestation of autism spectrum disorders (ASD) compared to children without ASD, researchers found two distinct patterns of language, social and motor development in the children with ASD.
As a result of last summer's deal to raise the federal debt ceiling, and the consequent failure of the congressional "super committee" to decide on budget cuts, states are bracing for automatic across-the-board cuts in education, social welfare and other programs for the upcoming 2013 fiscal year.
With an expanded focus on addressing peripheral arterial disease (PAD), Medtronic, Inc. (NYSE: MDT), today announced that it has completed enrollment in a clinical trial of the company's Complete SE (self-expanding) vascular stent for the treatment of atherosclerosis in the superficial femoral artery (SFA), including the proximal popliteal artery (PPA), which runs under the skin of the thigh.
Scientists at The University of Nottingham are to use MRI technology to discover whether abnormalities in the decision-making part of the brain could make some people more likely to become addicted to drugs.
› Verified 5 days ago